Taysha Gene Therapies Inc (NASDAQ:TSHA) has a beta value of 0.37 and has seen 28.04 million shares traded in the last trading session. The company, currently valued at $451.09M, closed the last trade at $2.24 per share which meant it gained $0.08 on the day or 3.46% during that session. The TSHA stock price is -92.86% off its 52-week high price of $4.32 and 74.55% above the 52-week low of $0.57. The 3-month trading volume is 2.35 million shares.
Taysha Gene Therapies Inc (NASDAQ:TSHA) trade information
Sporting 3.46% in the green in last session, the stock has traded in the red over the last five days, when the TSHA stock price touched $2.24 or saw a rise of 24.83%. Year-to-date, Taysha Gene Therapies Inc shares have moved 26.55%, while the 5-day performance has seen it change -24.32%. Over the past 30 days, the shares of Taysha Gene Therapies Inc (NASDAQ:TSHA) have changed -29.34%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Taysha Gene Therapies Inc (TSHA) estimates and forecasts
Figures show that Taysha Gene Therapies Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 29.11% over the past 6 months, with this year growth rate of 55.21%, compared to 10.70% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -137.69% over the past 5 years.
TSHA Dividends
Taysha Gene Therapies Inc is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
